RxDoctor Payments Data

Francisco Lebron-Arzon, MD

Pain Medicine · Bayamon, PRNPI 1629005863

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Boston Scientific at 44.5% of the total. Reporting peaked in 2019 at $20,949 and has fallen 97.2% since, to $577 in 2025. Among pain medicine clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,091in general payments, 2019–2025

Across 224 payments — averaging $143.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$14K
  • Abbott$11K
  • Medtronic$7K
  • Eisai Inc.$124
  • Pfizer Pharmaceuticals LLC$18
  • Merck$18
  • plus $12 from 1 others

What the payments were for

  • Consulting fees$6,60021%
  • Speaking & faculty fees$13,54042%
  • Travel & lodging$2,7098%
  • Food & beverage$9,12828%
  • Education$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific72$14,266
Abbott67$10,534
Medtronic(2 entities)81$7,119
Eisai Inc.1$124
Pfizer Pharmaceuticals LLC1$18
Merck1$18
PBG Puerto Rico LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,091 in reported general payments places this provider in the 90th percentile of 46 pain medicine providers in Puerto Rico.

See all pain medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$6,370
Medicare patients
12
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin875$14,760
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen375$5,478
Lidocaine39$4,275
Pregabalin131$3,149
Tizanidine Hcl344$2,257
Celecoxib274$2,191
Acetaminophen-CodeineAcetaminophen With Codeine84$1,940
Tramadol Hcl353$1,830
Oxcarbazepine27$1,484
Cyclobenzaprine Hcl220$1,078
Baclofen92$997
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen57$888
Duloxetine Hcl46$612
Meloxicam167$578
Diclofenac Sodium17$465

Paid to pharmacies, not to this prescriber.

Other pain medicine in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →